Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Symbol
ALGS on Nasdaq
Shares outstanding
5,381,598
Price per share
$8.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,651,648
Total reported value
$25,986,937
% of total 13F portfolios
0%
Share change
-52,752
Value change
+$21,300
Number of holders
33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alyeska Investment Group, L.P. 10% $2,162,400 530,000 Alyeska Investment Group, L.P. 31 Mar 2025
Woodline Partners LP 8.7% -11% $4,607,078 -$492,994 468,199 -9.7% Woodline Partners LP 30 Sep 2025
Sio Capital Management, LLC 5.5% $2,648,171 355,937 Sio Capital Management, LLC 30 Jun 2025
EcoR1 Capital, LLC 3.9% $859,387 210,634 EcoR1 Capital, LLC 31 Mar 2025
Adage Capital Management, L.P. 3.9% -61% $1,514,100 -$829,150 210,000 -35% Adage Capital Management, L.P. 30 Jun 2025
ARMISTICE CAPITAL, LLC 5% $768,827 188,438 Armistice Capital, LLC 31 Dec 2024
BLATT LAWRENCE 3.2% $716,077 175,509 Lawrence M. Blatt, Ph.D. 10 Mar 2025

As of 30 Sep 2025, 33 institutional investors reported holding 2,651,648 shares of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS). This represents 49% of the company’s total 5,381,598 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS) together control 49% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Woodline Partners LP 8.7% 468,199 -9.7% 0.02% $4,588,350
Deep Track Capital, LP 8.3% 444,110 0% 0.12% $4,352,278
Alyeska Investment Group, L.P. 7.7% 412,000 0% 0.01% $4,037,600
Sio Capital Management, LLC 6.2% 335,937 0% 0.83% $3,292,183
READYSTATE ASSET MANAGEMENT LP 3.8% 203,113 +48% 0.1% $1,990,507
VANGUARD GROUP INC 3.2% 171,689 +23% 0% $1,682,552
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.6% 140,000 0% 0% $1,372,000
BAKER BROS. ADVISORS LP 1.5% 83,055 0% 0.01% $813,939
HHLR ADVISORS, LTD. 1.4% 76,247 0% 0.02% $747,221
LPL Financial LLC 1% 55,120 +83% 0% $540,176
RENAISSANCE TECHNOLOGIES LLC 1% 55,019 +4.7% 0% $539,186
GEODE CAPITAL MANAGEMENT, LLC 0.87% 47,080 +38% 0% $461,594
TWO SIGMA INVESTMENTS, LP 0.72% 38,995 +223% 0% $382,151
Squarepoint Ops LLC 0.57% 30,493 +64% 0% $298,831
UBS Group AG 0.3% 16,182 +490% 0% $158,584
BlackRock, Inc. 0.24% 13,040 0% 0% $127,792
MORGAN STANLEY 0.21% 11,284 +182% 0% $110,583
CITADEL ADVISORS LLC 0.19% 10,310 -32% 0% $101,038
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.19% 10,107 0% $99,049
NorthCrest Asset Manangement, LLC 0.19% 10,000 0% $98,400
AlphaQuest LLC 0.13% 6,772 +14% 0% $66,366
WELLS FARGO & COMPANY/MN 0.06% 3,170 -77% 0% $31,066
Golden State Wealth Management, LLC 0.05% 2,674 0% 0% $26,205
ROYAL BANK OF CANADA 0.04% 2,125 0% 0% $21,000
BANK OF AMERICA CORP /DE/ 0.04% 1,914 -27% 0% $18,757

Institutional Holders of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 10,004 $84,138 $8.96 2
2025 Q3 2,651,648 $25,986,937 +$21,300 $9.80 33
2025 Q2 2,706,213 $19,511,284 -$4,851,099 $7.21 37
2025 Q1 3,295,608 $27,078,858 +$7,676,587 $8.25 35
2024 Q4 1,618,304 $64,472,927 +$11,786,170 $39.84 32
2024 Q3 1,692,019 $14,651,229 +$14,572,683 $8.66 27